Yi Fang Biology: Expected net loss of 317 million yuan for fiscal year 2025

2026-03-21 00:33:12

Yifang Biotechnology announces that it is expected to achieve operating revenue of 37.3253 million yuan and a net profit attributable to the parent company of -317 million yuan in 2025. The main financial data for this reporting period are preliminary calculations and have not been audited by an accounting firm. In 2025, the company’s performance changes will mainly be influenced by the combined effects of R&D investment intensity and revenue composition.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes